Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome

Actual Issues of Ischemic and Hemorrhagic Events Risk Management During Antithrombotic Therapy in Patients with Acute Coronary Syndrome

Today, optimal duration of double antiplatelet (DAPT) and triple antithrombotic therapy (TATT) in patients with acute coronary syndrome (ACS) remains the subject of scientific and practical discussion on possibilities of ischemic and hemorrhagic risks assessment. Good clinical risk metrics is based...

Full description

Bibliographic Details
Main Authors:	R. M. Velieva, T. B. Pecherina, A. S. Vorobiev, V. V. Kashtalap, D. Yu. Sedykh
Format:	Article
Language:	English
Published:	Столичная издательская компания 2020-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	acute coronary syndrome antiplatelet therapy hemorrhagic and ischemic events risk assessment
Online Access:	https://www.rpcardio.online/jour/article/view/2362

Similar Items

Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo)
by: D. Yu. Sedykh, et al.
Published: (2020-01-01)

NOVEL APPROACH TO ANTITHROMBOTIC TREATMENT OF ACUTE CORONARY PATIENTS WITH RIVAROXABAN
by: I. N. Bokarev, et al.
Published: (2015-07-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

The impact of antiplatelet drugs on recurrent stroke in patients with intracerebral hemorrhage
by: Yi-Sin Wong, et al.
Published: (2023-11-01)

TIMELINE FOR THE DOUBLE ANTIPLATELET THERAPY. FACTS AND SUGGESTIONS
by: O. L. Barbarash, et al.
Published: (2016-02-01)

Advances in Intensified Antithrombotic Therapies in Acute Coronary Syndrome
by: DENG Tianhua, HUANG Lin, YOU Zhigang
Published: (2023-03-01)

Antithrombotic treatment after intracerebral hemorrhage: Surveys among stroke physicians in Scandinavia and the United Kingdom
by: Elisabeth Forfang, et al.
Published: (2023-01-01)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
by: Shin‐Yi Lin, et al.
Published: (2022-03-01)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
by: Clara Bonanad, et al.
Published: (2022-05-01)

Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1‐Year Results of the PENDULUM Registry
by: Masato Nakamura, et al.
Published: (2020-05-01)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
by: Eleonora Gaetani, et al.
Published: (2020-06-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017-04-01)

Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
by: Dániel Tornyos, et al.
Published: (2021-05-01)

Periprocedural Antithrombotic Treatment During Acute Mechanical Thrombectomy for Ischemic Stroke: A Systematic Review
by: Rob A. van de Graaf, et al.
Published: (2018-04-01)

Practical aspects of antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Zh. D. Kobalava, et al.
Published: (2021-10-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
by: Wilbert Bor, et al.
Published: (2020-06-01)

Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01)

Platelet antiaggregants in the treatment and prevention of ischemic stroke
by: Andrei Viktorovich Fonyakin
Published: (2013-12-01)

Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
by: Menozzi Mila, et al.
Published: (2012-10-01)

Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
by: Clara Bonanad, et al.
Published: (2022-03-01)

Myocardial infarction and ischemic hepatitis complicated by postpartum hemorrhage
by: Meng-Han Chou, et al.
Published: (2016-06-01)

Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
by: Lili Wei, et al.
Published: (2020-07-01)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
by: Anne-Marije Hulshof, et al.
Published: (2021-12-01)

Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?
by: Renzo Laborante, et al.
Published: (2022-10-01)

Effect of dual antiplatelet therapy prolongation in acute coronary syndrome patients with both high ischemic and bleeding risk: insight from the OPT-CAD study
by: Kun Na, et al.
Published: (2023-09-01)

Impact of Diabetes Mellitus on Antithrombotic Management Patterns and Long‐Term Clinical Outcomes in Patients With Acute Coronary Syndrome: Insights From the EPICOR Asia Study
by: Shaoyi Guan, et al.
Published: (2020-11-01)

Algorithm for antithrombotic therapy in patients with ischemic stroke after thrombolysis
by: MA Domashenko, et al.
Published: (2014-12-01)

Patient after myocardial infarction: how to reduce the risk of recurrent ischemic events?
by: O. L Barbarash, et al.
Published: (2015-06-01)

Influence of an abnormal ankle-brachial index on ischemic and bleeding events in patients undergoing percutaneous coronary intervention
by: Hangyul Kim, et al.
Published: (2023-05-01)

Extended Pseudo-Subarachnoid Hemorrhage Post-Percutaneous Coronary Intervention
by: Benjamin Honton, MD, et al.
Published: (2020-12-01)

Antithrombotic Therapy Increases the Risk of Bleeding after Endoscopic Submucosal Dissection for Early Gastric Cancer: A Propensity Score-Matched Analysis
by: Tae-Se Kim, et al.
Published: (2023-05-01)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
by: S. Ramesh, et al.
Published: (2020-11-01)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
by: So-Ryoung Lee, et al.
Published: (2022-08-01)

Left Atrial Appendage Occlusion and Post-procedural Antithrombotic Management
by: Anders Kramer, et al.
Published: (2024-01-01)

Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy
by: Olga Baturina, et al.
Published: (2023-09-01)

Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
by: Yohei Numasawa, et al.
Published: (2020-06-01)

Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study
by: Ni Suo, et al.
Published: (2022-03-01)

Long term dual antiplatelet therapy after myocardial infarction: retrospective analysis in an outpatient population
by: Gennaro Ratti, et al.
Published: (2021-09-01)

Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low‐Dose Prasugrel or Clopidogrel
by: Gabriele Crimi, et al.
Published: (2019-01-01)

Hemorrhagic stroke during the acute phase of myocardial infarction: a rare and difficult situation to manage
by: Abdelaziz Boudihi, MD, et al.
Published: (2023-03-01)